Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

'Covid detection dogs' trial to get underway
The trial will establish whether the dogs could be used as a potentially new non-invasive, early warning mesaure to detect coronavirus.

Dogs could provide a fast, non-invasive detection method for COVID-19.

A trial which will be able to see if specially-trained 'COVID dogs' can detect coronavirus in humans, even if they are not showing symptoms, is set to get underway in the UK.

It is hoped that the trial will establish whether the dogs could be used as a potentially new non-invasive, early warning measure to detect coronavirus in the future.

The first phase of the trial will be conducted by researchers at the London School of Hygiene & Tropical Medicine (LSHTM) in partnership with Medical Detection Dogs and Durham University. Backed by half a million pounds of government funding, it aims to see if dogs can detect coronavirus in humans from odour samples.

Medical Detection Dogs has successfully trained dogs to detect the odour of many different diseases in humans, such as cancer, malaria and Parkinson's disease. This new trial will see if the dogs can be trained to detect COVID-19 in people too, even if they are asymptomatic.

“Bio-detection dogs already detect specific cancers and we believe this innovation might provide speedy results as part of our wider testing strategy," explained innovation minister Lord Bethel. “Accuracy is essential so this trial will tell us whether ‘covid dogs’ can reliably detect the virus and stop it spreading.”

If the initial trial is successful, the dogs could be used to provide a fast, non-invasive detection method for COVID-19. It is one of several testing measures being explored to ensure a swift response to the outbreak.

In the first phase of the trial, NHS staff will collect odour samples from people who are infected with coronavirus and those who are not infected. Six medical detection dogs will then undergo thorough training to identify the virus from the samples.

Years of research shows that dogs can detect the odour of disease at the equivalent dilution of one teaspoon of sugar in two Olympic-sized swimming pools of water. Researchers estimate the covid detection dogs may be able to screen as many as 250 people per hour.

“Our previous work has shown that malaria has a distinctive odour, and with Medical Detection Dogs, we successfully trained dogs to accurately detect malaria,” commented Professor James Logan, lead researcher for the work and Head of the Department of Disease Control at the London School of Hygiene & Tropical Medicine.

“This, combined with the knowledge that respiratory disease can change body odour, makes us hopeful that the dogs can also detect COVID-19.”

Medical Detection Dogs CEO and co-founder Dr Claire Guest, added: “We are delighted that the government has given us the opportunity to demonstrate that dogs can play a role in the fight against COVID-19. They have the potential to help by quickly screening people, which could be vital in the future.

“We have already demonstrated our expertise in canine disease detection by successfully training dogs to detect diseases like cancer, Parkinson’s and malaria, and we apply that same science to train life-saving Medical Alert Assistance Dogs to detect odour changes in individuals caused by their health condition.”

She added: “We are sure our dogs will be able to find the odour of COVID-19 and we will then move into a second phase to test them in live situations, following which we hope to work with other agencies to train more dogs for deployment. We are incredibly proud that a dog’s nose could once again save many lives.”

Image (C) Medical Detection Dogs.

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.